Literature DB >> 3605840

Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.

E K Motoyama, M D Fort, K W Klesh, R L Mutich, R D Guthrie.   

Abstract

Pulmonary function during the early development of bronchopulmonary dysplasia (BPD) in premature infants is not well understood. Furthermore, it is not known how early airway reactivity appears in BPD. During a 14-month period we studied 32 infants (mean gestational age, 27.3 wk; mean birth weight, 1.02 kg) with respiratory distress syndrome in whom BPD eventually developed. We obtained maximal expiratory flow-volume (MEFV) curves by manual inflation of the lung followed by forced deflation with a negative pressure on 64 occasions (mean postnatal age, 43.1 days). At each test MEFV curves were obtained in 3 conditions: baseline; after normal saline aerosolization with manual ventilation as a control; and after bronchodilator. Maximal expiratory flow at 25% of FVC (Vmax25) was markedly decreased at baseline and remained decreased after saline control. The FVC also was decreased in both baseline and saline control studies. After bronchodilator there was a marked (p less than 0.001) increase in Vmax25 (+214% above saline control) together with a significant (p less than 0.001) increase in FVC (+21%). Of 23 infants studied after 3 wk of postnatal age, 21 exhibited a more than 30% increase in Vmax25 above control (defined as airway reactivity). The remaining 2 infants were already receiving bronchodilator therapy. The most premature infant with demonstrable airway reactivity was 26 wk postconception, and the youngest was 12 days old. In 13 infants who were studied initially before 3 wk of age, there was a highly significant correlation (r = 0.91 p less than 0.001) between the degree of airway reactivity and the severity of respiratory disease as determined by the duration of ventilator dependence. Airway reactivity may play an important role in the development and severity of BPD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605840     DOI: 10.1164/ajrccm/136.1.50

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  27 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease.

Authors:  S Stick
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 3.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

4.  New aerosol delivery system for neonatal ventilator circuits.

Authors:  M L Everard; J Stammers; J G Hardy; A D Milner
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

5.  Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values.

Authors:  Anastassios C Koumbourlis; Xin C Chen; J Sunil Rao; Mark D Schluchter; Kirk Easley; Andrew A Colin; Peter Hiatt; Meyer Kattan; Kevin McCarthy; Robert B Mellins; Hannah Peavy; Arnold C G Platzker; Suzanne Steinbach; Andrew Ting; Michael D Weisner; Mary Ellen B Wohl
Journal:  Pediatr Pulmonol       Date:  2004-04

Review 6.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

7.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

8.  Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP.

Authors:  A Ben-Jebria; R Marthan; M Rossetti; J P Savineau
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

Review 9.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease.

Authors:  T F Fok; K Lam; P C Ng; H K So; K L Cheung; W Wong; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.